Top Industry Leaders in the Lidocaine Market
Hospira, Inc., a Pfizer company, issued a voluntary nationwide recall of their Lidocaine Hydrochloride Injection due to the potential presence of glass particulate matter. This highlights the importance of quality control and patient safety in the Lidocaine market.
Sintetica® US announced its launch of Lidocaine Hydrochloride Injection, marking their first commercial product launch in the US. This could increase competition and potentially lead to lower prices for Lidocaine in the future.
3M continues to expand its Tegaderm® CHG line with the launch of Tegaderm® CHG Wipes with 2% CHG. This offers healthcare professionals another option for post-operative and chronic wound care, with Lidocaine included for pain relief.
Kimberly-Clark Professional launched their Kleenex® Brand CHG Skin Prep Wipes with 4% CHG. These wipes target healthcare settings for pre-procedural skin disinfection, often using Lidocaine in combination with Chlorhexidine Gluconate for enhanced pain relief.
List of Lidocaine Key companies in the market- SCILEX Pharmaceuticals, Inc.
- Hisamitsu Pharmaceutical Co., Inc.
- Jiangsu Tianji Pharmaceutical Co. Ltd.
- SOFMEDICA
- Perkin Elmer
- Medline Industries, Inc.
- SonoScape Medical Corp.
- Pfizer, Inc.
- KARL STORZ.
- Teikoku Pharma USA, Inc.
- Endomed Systems
- Actavis Labs UT Inc.
- Dun & Bradstreet, Inc.
- PENTAX Medical
